Desktop Health, a leading brand in production-grade medical 3D printing from Desktop Metal, Inc. (NYSE: DM), has validated its Flexcera® Smile Ultra+ resin for use in dental implantology, specifically for…
Battelle, renowned for its extensive expertise in research, laboratory analysis, and consulting on Per- and Polyfluoroalkyl Substances (PFAS), is now leveraging its skills in response to the growing awareness and…
HU Group Holdings Inc. and its subsidiary, Fujirebio, have announced the launch of the Lumipulse G GFAP assay for use on the fully automated, random-access LUMIPULSE® G immunoassay systems. This…
The Glycocalyx Research Institute is excited to announce groundbreaking results from a recent study exploring the impact of microvascular health—comprising the vast network of tiny capillaries in the body—on acute…
AtriCure, Inc. (Nasdaq: ATRC), a leader in innovative surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain, has announced regulatory approval from China’s National Medical…
Medpace Holdings, Inc. (Nasdaq: MEDP) announced its financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights: Year-to-Date 2024 Financial Summary: Balance Sheet and Financial…
NSF and the National Environmental Health Association (NEHA) have jointly announced Timothy Hatch, MPA, REHS, as the recipient of the 2024 Walter F. Snyder Environmental Health Award. This prestigious accolade…
Ora, a leading global contract research organization (CRO) specializing in ophthalmic research, has announced a strategic recapitalization by The Vistria Group, a middle-market private investment firm focused on delivering financial…
Novocuff, Inc., a medical device company focused on enhancing pregnancy outcomes and minimizing the risk of preterm birth, has successfully concluded an oversubscribed $26 million Series A funding round following…
Politan Capital Management, along with its affiliates holding an 8.9% stake in Masimo Corporation (NASDAQ: MASI), has released a statement from Michelle Brennan, an independent director of Masimo: “When I…
Oticon Medical announced today that the U.S. Food and Drug Administration (FDA) has approved its Sentio™ System, the company’s first active transcutaneous bone conduction hearing system. Offering enhanced features over…
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant in the…